atrial fibrillation

In other work, endurance athletes have exhibited elevated rates of AFib.

AFib can occur spontaneously and irregularly and resolve on its own (paroxysmal AFib) or be persistent.

People with AFib are five times more likely to have a stroke than those who do not have the condition, and these strokes are more severe and more likely to be fatal than strokes not associated with AFib.

Women tend to have different risk factors precipitating AFib than men, which could explain some of the difference in outcomes.

Food and Drug Administration (FDA)-cleared Kardia Mobile device and app-based service has responded to this issue with clinically validated mobile electrocardiogram (ECG) technology to detect AFib on the go.

While AFib isn't immediately life-threatening, it can impede blood flow from the heart to the body, causing fatigue, breathlessness and chest pain.

Headquartered in Paris, Cardiologs Technologies is a privately held company offering the Cardiologs ECG Analysis platform to aid cardiologists in screening for arrhythmias such as AFib using long-duration ambulatory ECG monitoring recordings.

AFib can feel like the heartbeat is quivering or skipping beats.

Screening for atrial fibrillation (AFib) seems to be a promising application, especially considering the 30 percent of AFib cases that go completely undiagnosed.

AFib can cause fatigue, palpitations, shortness of breath, confusion, chest pains and even strokes.

The study participants who followed a weight-management plan (800 to 1,200 calories per day) experienced a decrease in the severity and frequency of AFib symptoms (including heart palpitations, breathlessness, and chest pain) and reduced their number of episodes of AFib by more than half, compared with those who received only nutrition and fitness advice.

This tool will be very helpful because AFib is so hard and expensive to diagnose," Dr.

WHAT AFIB PATIENTS ARE THINKING ABOUT STROKES: ARE AT RISK 50% ARE NOT AT RISK 25% ARE NOT SURE 25% Note: Table made from pie chart.

Pradaxa (150 mg), which is taken twice daily, has been shown to reduce stroke and systemic embolism by 35% beyond the reduction achieved with warfarin, the current standard of care for patients with AFib, Boehringer Ingelheim reports, adding that Pradaxa significantly reduced ischemic and hemorrhagic strokes compared with warfarin.

lt;p>More generally, some respondents considered that the definition of an AFIB as set out in the draft statutory instrument was too restrictive and there were additional regulatory requirements which were not applicable to conventional debt securities (article 77 instruments).